GVK
Vice Chairman at GVK
About
I am a high-level executive and entrepreneur with a career spanning infrastructure, healthcare, and venture capital. Currently, I serve as Vice Chairman at GVK and GVK EMRI, where I oversee large-scale projects including emergency services that support over 800 million people in India. I also founded Aragen Life Sciences, a major pharmaceutical services organization, and lead Reddy Ventures and Jivi AI. My work is driven by a passion for large-scale impact, particularly in how generative AI can transform global healthcare and how infrastructure serves as a catalyst for economic growth. I am currently focused on scaling these initiatives and exploring new opportunities at the intersection of technology and public service. I am always looking to connect with others who are passionate about driving systemic change through innovation.
Networking
What I can offer
- ›Strategic oversight for large-scale infrastructure projects
- ›Guidance on healthcare innovation and AI integration
- ›Venture capital and incubation expertise
Looking for
- ›expanding my professional network
- ›exploring mutual opportunities in infrastructure, healthcare, and technology
Best fit for
Current Interests
Background
Career
Started at Aragen Life Sciences in 2001, moved into infrastructure and emergency services with GVK in 2009, expanded into venture capital with Reddy Ventures in 2021, and co-founded Jivi AI in 2023.
Education
Stanford Executive Program, Stanford University Graduate School of Business (2022); MBA, University of Michigan (1987–1989)
Achievements
- ›GVK EMRI provides emergency services to over 800 million people, managing 60,000–80,000 emergencies daily and saving over 5 million lives.
- ›Founded Aragen Life Sciences, one of Asia’s largest pharmaceutical services companies with over 2,500 scientists.
Opinions
- Generative AI has the potential to transform healthcare for billions of people globally.
- Infrastructure development is a fundamental requirement for India to fulfill its economic potential.